awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33944980-6C844265-A596-4447-B7A9-7192F9EEFCF1
Q33944980-6C844265-A596-4447-B7A9-7192F9EEFCF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33944980-6C844265-A596-4447-B7A9-7192F9EEFCF1
Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.
P2860
Q33944980-6C844265-A596-4447-B7A9-7192F9EEFCF1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33944980-6C844265-A596-4447-B7A9-7192F9EEFCF1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c842928f422b6178c61c1e4cec4af32c615869f
P2860
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.